Please ensure Javascript is enabled for purposes of website accessibility Transformational Growth ETF JXX - Janus Henderson Investors - US Advisor
For Financial Professionals in the US

JXX Transformational Growth ETF

Aims to generate long-term outperformance through exposure to companies with transformative growth potential

NAV
$26.52
As of 07/17/2025

1-Day Change
$0.31 (1.18%)
As of 07/17/2025

ITD Return
6.13%
As of 07/17/2025

Overview

About this ETF

For investors seeking an active fund that offers growth exposure away from the benchmark. JXX seeks to provide thoughtful diversification with high active share by investing in companies we believe to have transformative growth potential.

Why Invest in this ETF

Focus on Secular Themes
Investing in companies we believe to be benefiting from durable trends transforming society

Legacy of Growth Investing
Rigorous fundamental equity research seeks to identify superior business models

Highly Active Diversification
Focused portfolio provides thoughtful diversification away from the index and across transformative growth opportunities

Portfolio Management

Nick Schommer, CFA

Portfolio Manager

Industry since 2007. Joined Firm in 2013.

Brian Recht

Portfolio Manager | Research Analyst

Industry since 2011. Joined Firm in 2015.

Performance

RETURNS (%) (As of 06/30/2025)
Nav Market-Price Russell 1000® Growth Index
 
3M Since Inception
(02/04/2025)
Nav 18.60 3.45
Market-Price 18.65 3.45
Russell 1000® Growth Index 17.84 3.90
RETURNS (%) (As of 06/30/2025)
Nav Market-Price Russell 1000® Growth Index
 
3M Since Inception
(02/04/2025)
Nav 18.60 3.45
Market-Price 18.65 3.45
Russell 1000® Growth Index 17.84 3.90

Premium/Discount History

Portfolio

Index represents the Russell 1000® Growth Index

Top Holdings (As of 07/16/2025)
% of Fund
Oracle Corp 10.02
Taiwan Semiconductor Manufacturing Co Ltd (ADR) 8.35
Broadcom Inc 7.58
Amazon.com Inc 7.28
Intercontinental Exchange Inc 6.50
Howmet Aerospace Inc 5.34
DraftKings Inc 4.34
Booking Holdings Inc 4.17
Datadog Inc 4.11
Madrigal Pharmaceuticals Inc 4.07
View full holdings
Portfolio Characteristics (As of 07/16/2025)
 
Number of Holdings
Equity Issues
23
Market Capitalization
Weighted Average
$498.40B
Portfolio Turnover Rate
(1-year trailing)
-
Price/Earnings Ratio
(1-year forward)
41.49
Price/Book Ratio
13.04
Earnings Growth Rate
(1-year forward)
21.22%

Documents